Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Biomedical Instrumentation & Technology
|
October 9, 2013
Safety vs. safety
Matt Braun
Journal of Autism and Developmental Disorders
|
October 22, 2014
Brief report: use of interactive television in identifying autism in young children: methodology and preliminary data
R Matthew Reese, T Rene Jamison, Matt Braun, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 30, 2001
LC/MS/MS plasma assay for the peptidomimetic VLA4 antagonist I and its major active metabolite II: for treatment of asthma by inhalation
Alison L Fisher, Elizabeth DePuy, Andrew Jayaraj, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 30, 2006
Metabolism of MK-0524, a prostaglandin D2 receptor 1 antagonist, in microsomes and hepatocytes from preclinical species and humans
Brian J Dean, Steve Chang, Maria Victoria Silva Elipe, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 21, 2010
Metabolism and excretion of [14C]taranabant, a cannabinoid-1 inverse agonist, in humans
Bindhu Karanam, Carol Addy, Thomas Bateman, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 11, 2006
In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites
Deborah A Nicoll-Griffith, Carmai Seto, Yves Aubin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Biomedical Instrumentation & Technology
|
October 9, 2013
Safety vs. safety
Matt Braun
Journal of Autism and Developmental Disorders
|
October 22, 2014
Brief report: use of interactive television in identifying autism in young children: methodology and preliminary data
R Matthew Reese, T Rene Jamison, Matt Braun, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
October 30, 2001
LC/MS/MS plasma assay for the peptidomimetic VLA4 antagonist I and its major active metabolite II: for treatment of asthma by inhalation
Alison L Fisher, Elizabeth DePuy, Andrew Jayaraj, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
November 30, 2006
Metabolism of MK-0524, a prostaglandin D2 receptor 1 antagonist, in microsomes and hepatocytes from preclinical species and humans
Brian J Dean, Steve Chang, Maria Victoria Silva Elipe, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
August 21, 2010
Metabolism and excretion of [14C]taranabant, a cannabinoid-1 inverse agonist, in humans
Bindhu Karanam, Carol Addy, Thomas Bateman, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 11, 2006
In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites
Deborah A Nicoll-Griffith, Carmai Seto, Yves Aubin, et al.
Page
of 1